Ufp Technologies (UFPT) Capital Expenditures Growth (3y) (2013 - 2025)
Ufp Technologies (UFPT) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 2.15% |
| 10 | Ufp Technologies | 1.89 Bn | 1.87 Bn | 44.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -64.51% |
| Jun 30, 2025 | -22.63% |
| Mar 31, 2025 | 6.47% |
| Sep 30, 2024 | -48.81% |
| Jun 30, 2024 | 14.77% |
| Mar 31, 2024 | 6.13% |
| Dec 31, 2023 | -99.16% |
| Sep 30, 2023 | 45.37% |
| Jun 30, 2023 | 34.83% |
| Mar 31, 2023 | 28.79% |
| Dec 31, 2022 | 28.50% |
| Sep 30, 2022 | 14.00% |
| Jun 30, 2022 | 62.74% |
| Mar 31, 2022 | 18.92% |
| Dec 31, 2021 | 7.22% |
| Sep 30, 2021 | -13.36% |
| Jun 30, 2021 | 6.98% |
| Mar 31, 2021 | -1.01% |
| Dec 31, 2020 | -27.93% |
| Sep 30, 2020 | -27.82% |